1.
Oral Dis
; 23(6): 749-756, 2017 Sep.
Article
in English
| MEDLINE
| ID: mdl-27606832
ABSTRACT
Leprosy is a chronic infectious disease caused by Mycobacterium leprae, a bacillus that has a tropism for skin and peripheral nerves. Leprosy treatment is based on a multidrug therapy established by the World Health Organization in 1982 and, despite its widespread use, Brazil ranks second worldwide in numbers of cases. Oral involvement in leprosy has been poorly described in the literature, and few studies have shown that although the bacillus is found in mucosa, specific leprosy lesions are rare and affect patients with advanced stages of the disease. This review aimed to assess the literature on oral manifestations in leprosy and the aspects involving oral cavity in leprosy pathogenesis.
Subject(s)
Antibodies, Bacterial/analysis , Facial Dermatoses/microbiology , Leprosy/complications , Mouth Diseases/microbiology , Mycobacterium leprae/immunology , Biomarkers/analysis , Humans , Leprosy/diagnosis , Leprosy/pathology , Saliva/immunology
2.
Rev Hosp Clin Fac Med Sao Paulo
; 44(2): 55-7, 1989.
Article
in Portuguese
| MEDLINE
| ID: mdl-2616987
3.
Rev Paul Med
; 105(3): 130-3, 1987.
Article
in Portuguese
| MEDLINE
| ID: mdl-3329758
4.
Brazilian Journal of Oral Sciences;3(8): 395-400,
in English
| URUGUAIODONTO
| ID: odn-18277